Last updated on May 2019

A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

Brief description of study

The primary objective of this study is to examine the effect of Levodopa-Carbidopa Intestinal Gel (LCIG) relative to that of OMT on non-motor symptoms associated with Parkinson's disease (PD).

Clinical Study Identifier: NCT02549092

Find a site near you

Start Over

Asan Medical Center /ID# 163018

Seoul, Korea, Republic of
  Connect »

Severance Hospital /ID# 163019

Seoul, Korea, Republic of
  Connect »